Mkts

Organogenesis Holdings Inc.

NASDAQ: ORGO
$0.81-0.03 (-3.18%)
As of Nov 6, 4:00 PM ET

Key statistics

Day range
0.750.91
52-week range
0.737.08
Today
Open0.78
Previous close0.81
Volume—
Valuation
Market cap104.64M
P/E ratio—
EPS (TTM)-0.69
Income & risk
Dividend / yield—
Beta1.50
Avg volume835.8K
Discussion

ORGO News

Stories mentioning ORGO from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue37,228225,607150,864101,00586,693126,656115,177130,234
Cost of Goods Sold23,72331,05126,79629,198
Gross Profit62,97095,60588,381101,036
Operating Expenses
Research & Development15,16110,28613,22110,39510,64011,53010,34415,587
Sales General & Admin65,186100,17479,74373,81072,50973,85671,79576,540
Total Operating Expenses106,119162,318130,137113,581113,439145,133108,935144,126
Operating Income (Loss)(68,891)63,28920,727(12,576)(26,746)10,2196,242(13,892)
Interest Income
Interest Expense620.00
Other Expense38.00(98.00)18.0073.002.00(27.00)52.00(28.00)
Pretax Income(68,473)63,42721,160(11,834)(25,783)10,2535,823(14,540)
Tax Provision(15,317)19,727(407.00)(2,442)(6,940)2,580(6,508)2,503
Net Income (Loss)(53,156)43,70021,567(9,392)(18,843)7,67312,331(17,043)
Earnings Per Share (Basic)(0.44)0.340.11(0.10)(0.17)0.060.09(0.13)
Earnings Per Share (Diluted)(0.44)0.340.11(0.10)(0.17)0.060.09(0.13)
Weighted Average Shares Outstanding (Basic)127,797126,738126,882126,854126,296131,673132,575132,573
Weighted Average Shares Outstanding (Diluted)127,797130,248130,849133,927126,296131,673133,927132,573

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ORGO

Organogenesis Holdings Inc. (NASDAQ: ORGO) is a stock listed on the Nasdaq Stock Market under the ticker symbol ORGO. It last traded at $0.8100 (Nov 6, 2026, 4:00 PM ET), down 3.2% on the day. That gives Organogenesis a market capitalisation of $104.6M.

Over the past 52 weeks ORGO has traded between $0.7300 and $7.08.

Revenue for the quarter ended Mar 31, 2026 was $37.2M; a net loss of $53.2M. Revenue was down 57.1% from $86.7M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$37.2M-$53.2M-142.8%
Dec 31, 2025$225.6M$43.7M19.4%
Sep 30, 2025$150.9M$21.6M14.3%
Jun 30, 2025$101.0M-$9.4M-9.3%

From Organogenesis’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…